Marshall Wace, LLP Iovance Biotherapeutics, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $12.5 Million - $22.9 Million	1,612,055 New	1,612,055 $12.9 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $155,448 - $307,746	35,011 New	35,011 $159,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $2.08 Million - $3.69 Million	369,463 New	369,463 $2.36 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $325,080 - $933,968	-50,953 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $10 Million - $15.5 Million	-810,207 Reduced 94.08%	50,953 $848,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $14 Million - $23.3 Million	843,293 Added 4719.84%	861,160 $16.4 Million
Q2 2021 Aug 13, 2021	SELL	$16.33 - $33.07 $390,809 - $791,431	-23,932 Reduced 57.25%	17,867 $465,000
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $1.2 Million - $2.2 Million	41,799 New	41,799 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $1.63 Million - $2.92 Million	-58,026 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $850,121 - $1.11 Million	30,635 Added 111.84%	58,026 $1.91 Million
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $745,309 - $1.12 Million	27,391 New	27,391 $752,000
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $38,083 - $75,718	-1,949 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $34,984 - $57,320	1,949 New	1,949 $54,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $5.54 Million - $13.9 Million	-566,016 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$8.41 - $11.26 $677,089 - $906,542	80,510 Added 16.58%	566,016 $5.38 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $3.65 Million - $5.79 Million	485,506 New	485,506 $4.3 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $360,937 - $491,397	-28,991 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $234,827 - $565,324	28,991 New	28,991 $490,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account